Cancer

Loren (left) and Dinny (right), who both lost their voices during their cancer treatment Human beings face many of their worst demons by expressing their emotions and sharing their experiences with others. For most patients, speaking out about a cancer diagnosis and voicing worries, fears, highs and lows, is an important way of dealing with
0 Comments
CRUK and UICC’s Tobacco Control Partnership in Kenya and Uganda is launched at the World Cancer Congress “Since the last World Cancer Congress in 2018, more than 25 million people have died from cancer. Around the world, the COVID-19 pandemic caused significant disruptions to services to prevent cancer and detect and treat it early. We
0 Comments
United Nations Climate Change Conference (COP26) In November 2021, Cancer Research UK Chief Clinician, Professor Charles Swanton, visited our longstanding corporate partner ScottishPower at their headquarters in Glasgow. He was there during the United Nations Climate Change Conference (COP26) to deliver the keynote speech at their ‘Air Pollution and Cancer’ event. This marked the start
0 Comments
We welcome two outstanding researchers – Kairbaan Hodivala-Dilke and Simon Boulton – as they join our group of funding committee chairs. Kairbaan Hodivala-Dilke is the new chair of our Research Careers Committee. Her research group investigates the molecular mechanisms underlying stromal contributions to tumour growth and therapy efficacy. Simon Boulton is Principal Group Leader of
0 Comments
In a new series focussing on research integrity, two of our experts will dig into the issues and challenges of this incredibly important aspect of research. In this first instalment, Dr Catherine Winchester explores the importance of the pre-submission review…     We all appreciate that peer review is an invaluable process for evaluating the quality,
0 Comments
Immunotherapy works by helping the body’s immune system recognise and attack cancer cells. There are several different types of immunotherapies, including monoclonal antibodies, vaccines, and, in this case, checkpoint inhibitors. Checkpoint inhibitors block specific proteins on the surface of immune cells called T cells. Blocking these proteins help T cells to recognise cancer cells as
0 Comments
We’ve all seen the headlines. Whether it’s ‘Waiting lists for cancer treatment soar’ in the Express, the Mail talking about ‘Record NHS waiting lists’ or the Guardian reporting ‘Waiting times for cancer care in England longest on record’, the pressure on NHS cancer services is hard to miss. But why are cancer waiting times so
0 Comments
The Armed Forces Institute of Pathology, US “Brain tumours are amongst the most difficult-to-treat cancers,” explains Professor Steve Clifford, Chair of Molecular Paediatric Oncology at the University of Newcastle. “It’s especially heartbreaking when they affect children.” Medulloblastoma is a children’s brain cancer that develops in the back of the brain, in an area called the
0 Comments
Lung cancer is the third most common cancer in the UK; every year around 48,500 people are diagnosed with the disease and unfortunately only 1 in 10 patients in England will survive their disease for 10 years or more. Those diagnoses are often late, as early symptoms can be easily mistaken for other, less serious,
0 Comments
Black in Cancer co-founders Dr Henry Henderson and Sigourney Bonner. (Photo by John Nicholson) Dr Faith Uwadiae spent 10 years studying science at some of London’s top universities and research institutes before she had the chance to attend a lecture by another Black woman. That lecture wasn’t actually about science, though. It took another year
0 Comments
At the recent Black in Cancer conference, we heard inspiring tales of community support and encouragement for Black researchers. This is something enshrined in the mentorship programme set-up by Black in Cancer to match students with a mentor scientist. We hear from mentor-mentee paring Melville and Jamie about the importance of representation, retention and hope…   
0 Comments